US Patent 11364214 Compositions and methods for treating eczema
Patent 11364214 was granted and assigned to Dermala on June, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Lada Rasochova0
Michelle Kem0
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113642140
Date of Patent
June 21, 2022
0Patent Application Number
163026390
Date Filed
May 18, 2017
0Patent Primary Examiner
CPC Code
Edits on 22 Jun, 2022
Golden AI
Edits made to:
Infobox (+32 properties)
Article (+524 characters)
US Patent 11364214 Compositions and methods for treating eczema
Article
Disclosed are compositions, methods of treatment using the compositions and methods of preparing the compositions for the treatment of eczema. The compositions may include propionic acid and/or non-steroidal esters of propionic acid. The compositions may further include a corticosteroid, immunomodulator, antibiotic, antibody, colloidal oatmeal, conditioned media prepared by bacterial fermentation, short chain fatty acids, picolinic acid, or emollient. The method of treatment may include analysis of the skin microbiome.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11364214
Date of patent
June 21, 2022
Patent application number
16302639
Date Filed
May 18, 2017
Patent primary examiner
Find more entities like US Patent 11364214 Compositions and methods for treating eczema
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.